Integrating New Options in Hepatocellular Carcinoma and Colorectal Cancer in the Community

Integrating New Options in Hepatocellular Carcinoma and Colorectal Cancer in the Community

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 2/18/2021

Max Credits: 1.25

View Activity

Chronic Lymphocytic Leukemia and Multiple Myeloma in the Community: Improving Outcomes with the Latest Clinical Advances

Chronic Lymphocytic Leukemia and Multiple Myeloma in the Community: Improving Outcomes with the Latest Clinical Advances

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 2/9/2021

Max Credits: 1.25

View Activity

Managing NSCLC and SCLC in the Community: What You Need to Know About the Latest Advances in Targeted Therapies and Immune Checkpoint Inhibitors

Managing NSCLC and SCLC in the Community: What You Need to Know About the Latest Advances in Targeted Therapies and Immune Checkpoint Inhibitors

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 2/26/2021

Max Credits: 1

View Activity

Updates in Newly Diagnosed PTCL

Updates in Newly Diagnosed PTCL

Peripheral T-cell lymphomas (PTCLs) are a highly heterogeneous and typical…

Expiration Date: 11/10/2020

Max Credits: 0.25

View Activity

Antibody-Drug Conjugates in PTCL

Antibody-Drug Conjugates in PTCL

Peripheral T-cell lymphomas (PTCLs) are a highly heterogeneous and typical…

Expiration Date: 11/10/2020

Max Credits: 0.25

View Activity

Updates in Diagnosis of PTCL and the Role of CD30

Updates in Diagnosis of PTCL and the Role of CD30

Peripheral T-cell lymphomas (PTCLs) are a highly heterogeneous and typical…

Expiration Date: 10/20/2020

Max Credits: 0.25

View Activity

Options for Relapsed/Refractory PTCL

Options for Relapsed/Refractory PTCL

Peripheral T-cell lymphomas (PTCLs) are a highly heterogeneous and typical…

Expiration Date: 10/20/2020

Max Credits: 0.5

View Activity

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

The treatment paradigm for the management of patients with advanced cancer…

Expiration Date: 7/7/2020

Max Credits: 1

View Activity

Oncology Consults: The Latest on the Biosimilar Revolution

Oncology Consults: The Latest on the Biosimilar Revolution

Several of the most-used cancer drugs are biologics and many, including ri…

Expiration Date: 6/27/2020

Max Credits: 0.75

View Activity

2019 Texas Oncology Clinical Educational Symposium

2019 Texas Oncology Clinical Educational Symposium

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 6/27/2020

Max Credits: 2.5

View Activity